← Eichor
Condition: Seizures Focal Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Seizures Focal

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
Phase 2 · 11 location(s) · Praxis Precision Medicines · NCT06908356Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
Phase 3 · 4 location(s) · Rapport Therapeutics Inc. · NCT07563881Real-world Clinical Response to Cenobamate Early add-on in France, Germany and Spain
Phase N/A · 1 location(s) · Aziende Chimiche Riunite Angelini Francesco S.p.A · NCT06716801Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
Phase 3 · 5 location(s) · Rapport Therapeutics Inc. · NCT07594119Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables
NA · 1 location(s) · Mayo Clinic · NCT07012148RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Phase 2 · 1 location(s) · Supernus Pharmaceuticals, Inc. · NCT06798896Multi-level Approach of Brain Activity Using Intracranial Electrodes in Epileptic Patients
NA · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04653012A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
Phase 3 · 95 location(s) · Xenon Pharmaceuticals Inc. · NCT05716100Oscillatory Activity in Basal Ganglia Circuits During Normal and Pathological Movement
NA · 1 location(s) · University Hospital, Bordeaux · NCT06241924A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Dr
Phase 1/Phase 2 · 3 location(s) · NaviFUS Corporation · NCT06388707A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures
Phase 2 · 7 location(s) · Rapport Therapeutics Inc. · NCT07219407REACH: RWE Retrospective Study to Evaluate Cenobamate Impact on Health Care Resource Utilization
Phase N/A · 10 location(s) · Aziende Chimiche Riunite Angelini Francesco S.p.A · NCT06922175Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell T
Phase 3 · 35 location(s) · Neurona Therapeutics · NCT05135091Changes in Attentional Control After a Focal Seizure.
Phase N/A · 1 location(s) · University Hospital, Lille · NCT06466681Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1)
Phase 2/Phase 3 · 26 location(s) · Praxis Precision Medicines · NCT06999902A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Phase 2/Phase 3 · 124 location(s) · Biohaven Therapeutics Ltd. · NCT06132893SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures
Phase 2 · 1 location(s) · Supernus Pharmaceuticals, Inc. · NCT07141329Epilepsy Learning Healthcare System (ELHS)
Phase N/A · 13 location(s) · Epilepsy Foundation of America · NCT06265103A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment
Phase 1 · 24 location(s) · Jazz Pharmaceuticals · NCT07233239Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastas
Phase 2 · 1 location(s) · Ayal A. Aizer, MD · NCT07130786A Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic Seizures
Phase 4 · 1 location(s) · Affiliated Hospital of Nantong University · NCT06967012Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures
Phase 3 · 7 location(s) · Praxis Precision Medicines · NCT07505004Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy
NA · 1 location(s) · University of California, San Francisco · NCT07680842Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy
Phase 2 · 10 location(s) · Supernus Pharmaceuticals, Inc. · NCT05518578Acute Effects of Focused Ultrasound Modulation on EEG Behavior in Status Epilepticus Patients
NA · 1 location(s) · Yale University · NCT05784805Neural Autoantibody Prevalence in New-onset Focal Seizures of Unknown Etiology
Phase N/A · 1 location(s) · Shen Chun-Hong · NCT06388161A Pilot Study to Evaluate the Efficacy and Safety of NaviFUS™ System Neuromodulating Treatment for Patients With Drug Re
NA · 1 location(s) · NaviFUS Corporation · NCT06492720Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy
Phase 1 · 1 location(s) · National Institute of Neurological Disorders and Stroke (NIN · NCT02531880
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.